Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Strategies for HPV prevention.

Martyn Plummer1, Silvia Franceschi

  • 1International Agency for Research on Cancer, 150 Cours Albert Thomas, F-69372 Lyon, France. plummer@iarc.fr

Virus Research
|November 26, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

European Code Against Cancer, 5th edition - cancer-causing infections and related interventions.

Molecular oncology·2026
Same author

Calibrating multiplex serology for Helicobacter pylori.

Diagnostic and prognostic research·2025
Same author

A Proof-of-Concept Clinical Trial Design for Evolutionary Guided Precision Medicine for Cancer.

medRxiv : the preprint server for health sciences·2025
Same author

Infectious pathogens and risk of esophageal, gastric and duodenal cancers and ulcers in China: A case-cohort study.

International journal of cancer·2023
Same author

Helicobacter pylori multiplex serology and risk of non-cardia and cardia gastric cancer: a case-cohort study and meta-analysis.

International journal of epidemiology·2023
Same author

Correction: On Bayesian modeling of censored data in JAGS.

BMC bioinformatics·2022
Same journal

Transcriptome analysis of African swine fever virus I9R-mediated modulation of host antiviral immunity.

Virus research·2026
Same journal

Corrigendum to "Two target cells for HPV infection at the cervix?" [Virus Res. 2026 , 369, 199754].

Virus research·2026
Same journal

Vaccination with an HSV-1 virus containing CD-137L reduces herpetic corneal disease when used both prophylactically and therapeutically.

Virus research·2026
Same journal

Ondansetron exhibits potent antiviral activity against enterovirus 71 infection in vitro and in vivo.

Virus research·2026
Same journal

Case report: A case of HIV seroconversion in a high-risk individual after 35 years of resistance with a CCR5Δ32 heterozygous genotype.

Virus research·2026
Same journal

Viruses under mechanical force: Implications and applications.

Virus research·2026
See all related articles

Human papillomavirus (HPV) prophylactic vaccines show high efficacy for cervical cancer prevention. Simpler field trials are crucial for demonstrating HPV vaccine effectiveness in developing nations lacking robust screening programs.

Area of Science:

  • Oncology
  • Vaccinology
  • Public Health

Background:

  • Cervical cancer is primarily caused by sexually transmitted human papillomavirus (HPV) types.
  • Behavioral changes like condom use show limited efficacy in preventing HPV infection.
  • Prophylactic HPV vaccines are anticipated to be highly effective for cervical cancer control.

Purpose of the Study:

  • To evaluate the effectiveness of HPV vaccination as a cervical cancer control strategy.
  • To advocate for the initiation of simpler, cost-effective HPV vaccine trials in developing countries.
  • To project the impact of mass HPV vaccination on cervical cancer incidence globally.

Main Methods:

  • Discusses the limitations of monitoring secular trends for vaccine effectiveness assessment.

Related Experiment Videos

  • Highlights the need for early, simpler field trials in resource-limited settings.
  • Considers study designs for HPV vaccine trials in Southern India and South Korea.
  • Includes projections of cervical cancer cases post-vaccination.

    • Main Results:

    • Phase III trials for HPV prophylactic vaccines are commencing, though they are expensive and complex.
    • Simpler field trials are essential to demonstrate HPV vaccine efficacy in real-world conditions, particularly in developing countries.
    • These trials may detect differences in severe preinvasive cervical lesions.

    Conclusions:

    • HPV vaccination is a promising strategy for cervical cancer prevention, especially in regions with high mortality and limited screening resources.
    • The implementation of HPV vaccination programs has the potential to significantly reduce the global burden of cervical cancer.
    • Further research and accessible trial designs are needed to confirm vaccine effectiveness in diverse populations.